|
Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn's disease
R Panaccione | RN Fedorak | G Anmais | et al
These guidelines are presented as a follow-up to the original
Canadian Association of Gastroenterology Clinical Practice
Guidelines: The use of infliximab in Crohn's disease, published
in the Canadian Journal of Gastroenterology (1). The original
guidelines represented publications between 1998 and 2000.
The current guidelines have been updated to reflect knowledge
gained from two pivotal randomized clinical trails, with the use
of infliximab in the maintenance of inflammatory Crohn's disease
in remission (2) and in the maintenance of fistulous
Crohn's disease in remission (3).
|